JOINT FILING STATEMENTJoint Filing Agreement • February 11th, 2022 • Dievini Hopp BioTech Holding GmbH & Co KG • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the common shares of Immatics N.V. and further agree that this Joint Filing Agreement be included as an exhibit to such joint filing.
